Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VOCOVID study of voclosporin versus tacrolimus in SARS-CoV-2 positive kidney transplant recipients
NL-OMON55051Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of voclosporin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Time to viral clearance of SARS-CoV-2. Started Nov 2020; status: active, not recruiting.
02
Drugs
voclosporin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON55051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55051.